Medicinal Chemistry of Nicotinamide in the Treatment of Ischemia and Reperfusion

被引:19
作者
Yang, J. [1 ]
Klaidman, L. K. [1 ]
Adams, J. D. [1 ]
机构
[1] Univ So Calif, Sch Pharm, Los Angeles, CA 90089 USA
关键词
D O I
10.2174/1389557024605483
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Nicotinamide can facilitate DNA repair by inhibiting poly(ADP-ribose) polymerase, increasing NAD levels and adjusting other related enzyme activities. This review will summarize recent work on the design of poly(ADP-ribose) polymerase inhibitors, poly(ADP-ribose) glycohydrolase inhibitors and will discuss the possible use of drugs that interact with NAD synthetic enzymes.
引用
收藏
页码:125 / 134
页数:10
相关论文
共 126 条
[31]  
Cristina C., 1999, ANN NY ACAD SCI, V890, P227
[32]   NICOTINAMIDE DECREASES NITRIC-OXIDE PRODUCTION AND PARTIALLY PROTECTS HUMAN PANCREATIC-ISLETS AGAINST THE SUPPRESSIVE EFFECTS OF COMBINATIONS OF CYTOKINES [J].
EIZIRIK, DL ;
SANDLER, S ;
WELSH, N ;
BENDTZEN, K ;
HELLERSTROM, C .
AUTOIMMUNITY, 1994, 19 (03) :193-198
[33]   THE UTILIZATION OF NICOTINAMIDE DERIVATIVES AND RELATED COMPOUNDS BY MAMMALS, INSECTS AND BACTERIA [J].
ELLINGER, P ;
FRAENKEL, G ;
KADER, MMA .
BIOCHEMICAL JOURNAL, 1947, 41 (04) :559-568
[34]  
ELLIOTT RB, 1993, ANN NY ACAD SCI, V696, P333
[35]  
Elvehjem CA, 1938, J BIOL CHEM, V123, P137
[36]   Protective effects of 5-iodo-6-amino-1,2-benzopyrone, an inhibitor of poly(ADP-ribose) synthetase against peroxynitrite-induced glial damage and stroke development [J].
Endres, M ;
Scott, GS ;
Salzman, AL ;
Kun, E ;
Moskowitz, MA ;
Szabó, C .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 351 (03) :377-382
[37]   Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase [J].
Endres, M ;
Wang, ZQ ;
Namura, S ;
Waeber, C ;
Moskowitz, MA .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1997, 17 (11) :1143-1151
[38]   Nicotinamide inhibits inducible nitric oxide synthase mRNA in primary rat glial cells [J].
Fujimura, M ;
Tominaga, T ;
Yoshimoto, T .
NEUROSCIENCE LETTERS, 1997, 228 (02) :107-110
[39]  
Gale EAM, 1996, J PEDIATR ENDOCR MET, V9, P375
[40]   THE ROLE OF INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASE AS RESISTANCE-MODIFYING AGENTS IN CANCER-THERAPY [J].
GRIFFIN, RJ ;
CURTIN, NJ ;
NEWELL, DR ;
GOLDING, BT ;
DURKACZ, BW ;
CALVERT, AH .
BIOCHIMIE, 1995, 77 (06) :408-422